Login to Your Account

BioMarin Abandons Neutralase; PKU Drug Tempting Genzyme?

By Randall Osborne

Monday, September 29, 2003

It's all about the enzymes. Strike that. More precisely, much drug development these days seems to be about the enzymes, as replacement therapies and as treatments.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription